top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

PHARMA

Innovent Biologics and Pfizer Forge $10.5 Billion Oncology Partnership

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

 Featured Articles. 

7-format11240.jpg
HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

7-format11240.jpg
BIOTECH

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up and it's Just Recruited its First Patients

7-format11240.jpg
SUSTAINABILITY

Engineering Crops From the Inside Out

7-format11240.jpg
PHARMA

AI in Science Writing and the Imitation of Understanding

7-format11240.jpg
PHARMA

Pharma Smart Manufacturing 2026

7-format11240.jpg
BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

7-format11240.jpg
BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

7-format11240.jpg
PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

7-format11240.jpg
BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

 Latest News. 

14th June, 2026

01.

Laverock Therapeutics Advances CAR-T and Macrophage Programmes with Solid Tumour Data

In-vivo results from both oncology programmes support lead candidate selection, as the UK biotech charts a path toward clinical trials.

3rd June, 2026

02.

Pharma Smart Manufacturing 2026

Europe's premier pharma conference on AI-enabled, GMP-compliant pharmaceutical manufacturing returns to Copenhagen.

29th May, 2026

03.

Innovent Biologics and Pfizer Forge $10.5 Billion Oncology Partnership

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

28th May, 2026

04.

Combat Medical Highlights Patient Impact of HIVEC HEAT Trial at AUA 2026

Phase 3 HIVEC® HEAT study presented at AUA 2026 highlights progress toward FDA registration and the potential for bladder-preserving treatment in high-risk NMIBC patients.

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page